| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | Dec 15, 2021 | Sale | $12.35 | 57,502 | 710,158 | 29,195 | Dec 17, 2021, 05:20 PM | |
| PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | Nov 16, 2021 | Sale | $14.36 | 57,502 | 825,982 | 29,195 | Nov 18, 2021, 06:42 PM | |
| PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | Apr 29, 2021 | Option Exercise | $21.09 | 6,446 | 135,945 | 3,667 | Apr 30, 2021, 06:22 PM | |
| PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | Apr 08, 2021 | Option Exercise | $20.94 | 200 | 4,189 | 544 | Apr 15, 2021, 07:11 PM | |
| PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | Apr 07, 2021 | Option Exercise | $20.97 | 2,000 | 41,933 | 1,444 | Apr 09, 2021, 05:52 PM | |
| PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | Sep 29, 2020 | Buy | $19.00 | 444 | 8,436 | 444 | Sep 29, 2020, 08:08 PM |
Menu